Industry Today Netherlands
SEE OTHER BRANDS

Catch up with industries and services news from the Netherlands

Industry Today Netherlands: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Industry Today Netherlands.

Press releases published on July 23, 2025

Tether and INHOPE Expand Partnership to Combat Online Child Exploitation

Tether and INHOPE Expand Partnership to Combat Online Child Exploitation

AMSTERDAM, NETHERLANDS, July 23, 2025 /⁨EINPresswire.com⁩/ -- INHOPE is pleased to announce an expanded partnership with Tether, the largest company in the digital assets industry, strengthening efforts to combat the illicit use of financial transactions …

AI and Global Collaboration Take Center Stage at Newsmatics’ Prague Workshop

AI and Global Collaboration Take Center Stage at Newsmatics’ Prague Workshop

Global teams met to discuss advancing products such as EIN Presswire, Perspectify and the Newsmatics News Index during strategy workshops. WASHINGTON , DC, UNITED STATES, July 23, 2025 /⁨EINPresswire.com⁩/ -- Newsmatics, a leader in AI-powered news …

Galapagos versterkt managementteam met ervaren life sciences leidinggevenden om bedrijfstransformatie te versnellen

Galapagos versterkt managementteam met ervaren life sciences leidinggevenden om bedrijfstransformatie te versnellen

Benoemt Sooin Kwon tot Chief Business Officer en Dan Grossman tot Chief Strategy Officer Beide leidinggevenden hebben een bewezen staat van dienst op het gebied van strategische uitvoering en het sluiten van deals en zullen helpen bij het stimuleren van …

Galapagos Bolster Leadership Team with Seasoned Life Sciences Executives to Accelerate Business Transformation

Galapagos Bolster Leadership Team with Seasoned Life Sciences Executives to Accelerate Business Transformation

Appoints Sooin Kwon as Chief Business Officer and Dan Grossman as Chief Strategy Officer Both executives possess proven track records in strategic execution and deal-making and will help drive long-term value creation at Galapagos Mechelen, Belgium; July …

Galapagos Welcomes Seasoned Pharmaceutical Executives Dawn Svoronos and Jane Griffiths to Its Board of Directors

Galapagos Welcomes Seasoned Pharmaceutical Executives Dawn Svoronos and Jane Griffiths to Its Board of Directors

New Directors bring deep commercial, operational, and transaction experience to the Board Mechelen, Belgium; July 23, 2025, 22:01 CET; Galapagos NV (Euronext …

Galapagos verwelkomt ervaren farmaceutische leidinggevenden Dawn Svoronos en Jane Griffiths in haar Raad van Bestuur

Galapagos verwelkomt ervaren farmaceutische leidinggevenden Dawn Svoronos en Jane Griffiths in haar Raad van Bestuur

Nieuwe Bestuurders brengen uitgebreide commerciële, operationele en transactionele ervaring mee naar de Raad van Bestuur Mechelen, België; 23 juli 2025, 22:01 CET; Galapagos NV (Euronext …

Galapagos Reports Half-Year 2025 Financial Results and Provides Second Quarter Business Update

Galapagos Reports Half-Year 2025 Financial Results and Provides Second Quarter Business Update

Appointments of new CEO, CFO, and seasoned business development leaders with proven track records of executing strategic transactions will position the Company to drive shareholder value and advance pipeline expansion Strategic alternatives for the cell …

Galapagos rapporteert halfjaarcijfers 2025 en geeft een update over de activiteiten in het tweede kwartaal

Galapagos rapporteert halfjaarcijfers 2025 en geeft een update over de activiteiten in het tweede kwartaal

De benoemingen van een nieuwe CEO, CFO en ervaren business development-leiders met bewezen ervaring in strategische transacties, versterken de positie van het bedrijf om aandeelhouderswaarde te creëren en de pijplijn uit te breiden Strategische …

Transaction in Own Shares

Transaction in Own Shares

Transaction in Own Shares 23 July, 2025 • • • • • • • • • • • • • • • • Shell plc (the ‘Company’) announces that on 23 July, 2025 it purchased the following number of Shares for cancellation. Aggregated information on Shares purchased according to trading …

AMG Schedule for Second Quarter 2025 Earnings Release

AMG Schedule for Second Quarter 2025 Earnings Release

Amsterdam, 23 July 2025 --- AMG Critical Materials N.V. ("AMG", EURONEXT AMSTERDAM: "AMG") will release its second quarter 2025 financial results on Wednesday, July 30, 2025, at approximately 18:00 CEST. AMG will host a conference call to discuss its …

Refresco Appoints Steve Presley as CEO

Refresco Appoints Steve Presley as CEO

Press Release Refresco Appoints Steve Presley as CEO Rotterdam, The Netherlands, July 23, 2025 – Refresco, the global independent beverage solutions provider, announces that Steve Presley has been appointed as the Company’s Chief Executive Officer, …

Philips advances minimally invasive therapy procedures in prostate cancer care with FDA 510(k) clearance for image-guided navigation technology

Philips advances minimally invasive therapy procedures in prostate cancer care with FDA 510(k) clearance for image-guided navigation technology

July 23, 2025 Supporting prostate cancer diagnosis with more precise guidance for clinicians, offering better patient care Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced a major …

VEON to Release 2Q25 Earnings Update on August 7, 2025

VEON to Release 2Q25 Earnings Update on August 7, 2025

VEON to Release 2Q25 Earnings Update on August 7, 2025 Dubai, July 23, 2025 – VEON Ltd. (NASDAQ: VEON), a global digital operator, today confirms that the Group will release its selected financial and operating results for the second quarter and half-year …

Pharvaris Announces Pricing of Upsized $175 Million Public Offering of Ordinary Shares and Pre-Funded Warrants

Pharvaris Announces Pricing of Upsized $175 Million Public Offering of Ordinary Shares and Pre-Funded Warrants

ZUG, Switzerland, July 22, 2025 (GLOBE NEWSWIRE) -- Pharvaris N.V. (“Pharvaris,” Nasdaq: PHVS), a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists to address unmet needs of those living with bradykinin-mediated …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions